A.L. Jaton
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Nerve injury and regeneration
Papers in
-
- Chemical synthesis and alkaloids 4
-
- Receptor Mechanisms and Signaling 3
- Phenothiazines and Benzothiazines Synthesis and Activities 2
- Co-authors
- A. Probst (1 shared paper)John Q. Trojanowski (1 shared paper)Karl‐Heinz Wiederhold (1 shared paper)Markus Tolnay (1 shared paper)Takeshi Ishihara (1 shared paper)R. Anthony Crowther (1 shared paper)M. G. Spillantini (1 shared paper)Claudia Mistl (1 shared paper)
- Journals
- Journal of Neural Transmission (3 papers)Clinical Neuropharmacology (2 papers)Pharmacology (1 paper)Life Sciences (1 paper)Acta Neuropathologica (1 paper)
- Partner nations
- JapanUnited KingdomSwitzerland
In The Last Decade
A.L. Jaton
18 papers receiving 487 citations
Peers
Comparison fields: 5 of 61
- Neurology 113
- Cellular and Molecular Neuroscience 247
- Physiology 274
- Neurology 101
- Developmental Neuroscience 19
Countries citing papers authored by A.L. Jaton
This map shows the geographic impact of A.L. Jaton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.L. Jaton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.L. Jaton more than expected).
Fields of papers citing papers by A.L. Jaton
This network shows the impact of papers produced by A.L. Jaton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.L. Jaton. The network helps show where A.L. Jaton may publish in the future.
Co-authors
The 25 scholars most cited alongside A.L. Jaton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 287 | |
| 2 | 1984 | 55 | |
| 3 | 1978 | 43 | |
| 4 | 1992 | 38 | |
| 5 | 1976 | 24 | |
| 6 | 1996 | 16 | |
| 7 | 1992 | 13 | |
| 8 | 1986 | 13 | |
| 9 | 1987 | 10 | |
| 10 | 1996 | 5 | |
| 11 | Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist. | 1976 | 5 |
| 12 | 1984 | 4 | |
| 13 | Neuropharmacology of bromocriptine and dihydroergotoxine (hydergine). | 1980 | 4 |
| 14 | 1978 | 4 | |
| 15 | 1989 | 2 | |
| 16 | 1978 | 2 | |
| 17 | 1993 | 1 | |
| 18 | 1992 | 1 |
About A.L. Jaton
A.L. Jaton is a scholar working on Organic Chemistry, Molecular Biology, Cellular and Molecular Neuroscience, Ecology, Evolution, Behavior and Systematics and Physiology, having authored 18 papers that have together received 527 indexed citations. Recurring topics across this work include Plant and fungal interactions (4 papers), Chemical synthesis and alkaloids (4 papers), Receptor Mechanisms and Signaling (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Neuropeptides and Animal Physiology (2 papers), Phenothiazines and Benzothiazines Synthesis and Activities (2 papers) and Growth Hormone and Insulin-like Growth Factors (2 papers). The work is most often cited by research in Neurology (113 citations), Cellular and Molecular Neuroscience (247 citations), Physiology (274 citations), Neurology (101 citations) and Developmental Neuroscience (19 citations). A.L. Jaton has collaborated with scholars based in Japan, United Kingdom and Switzerland. Frequent co-authors include A. Probst, John Q. Trojanowski, Karl‐Heinz Wiederhold, Markus Tolnay, Takeshi Ishihara, R. Anthony Crowther, M. G. Spillantini, Claudia Mistl, A.R. Dravid and Jürgen Götz. Their work appears in journals such as Journal of Neural Transmission, Clinical Neuropharmacology, Pharmacology, Life Sciences and Acta Neuropathologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.